VYRE Network

VYRE Network (CAPV) Now Integrated With Samsung TV

Las Vegas, Nevada--(Newsfile Corp. - December 10, 2021) - VYRE Network (OTC Pink: CAPV) (a wholly-owned Cabo Verde Capital company, "VYRE") is pleased to announce that...
CPRE Networks

Adding VYRE Network (CAPV) to the Watch List.

Look What We Found. Our First Internet Play in Ages, And It's a Doozy. We would categorize this...

Beachbody (BODY) Conference Call

"Make no mistake, as the single largest shareholder as well as CEO of Beachbody, but more so because I believe in the...

Adding Beach Body (BODY) $3.90 to the Watch List.

This is Like Shooting Fish in the Barrell, but the Fish Shoot Back. We’re not traders, but we...

Nautilus (NLS) $8.50, Numbers Out. Time to go Bottom Fishing?

Adding Nautilus to the Watch List. Conference Call Transcript Below New Street Targets at $15 per Share.
Internet Stock Review

Peloton Plunges $9 Billion in Value, on a $805 Million Quarter!

Peloton just reported the $805 million for three months worth of business ended September. That's $9 million worth of fitness everyday. And...

Telehealth Watch List.

We Haven't Looked at the Telehealth Watch List for a Spell and we Were Very Surprised at the YTD Performance.

Billion Dollar Aggregators Buying Mom-and-Pop Amazon Sellers. Simply Amazing.

At least 77 Amazon aggregators have raised roughly $10 billion in total since April 2020, according to Marketplace Pulse.
omniq

OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.

Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share. Without disrupting legacy sales - CEO Shai...

Hapbee’s (HAPB) TV Series, to Air Over Syndicated Television Networks.

New to The Street TV and Hapbee Technologies, Inc. Sign Contract for 12 Part TV Series Across Syndicated Television Networks

Latest article

Revive therapeutics

Our Best Risk to Reward Idea Ever?

Adding Revive Therapeutics (RVVTF, RVV.CN) to the "2022, Biotech 12 pack, 12 Biotech Stocks We Expect to...
Immunix Bio

ImmixBio (IMMX) Announces Positive Clinical Trial Safety Data.

Demonstrates 100% Completion of Planned Treatment Cycles. Immix Biopharma, Inc. Wed, January 19, 2022. ImmixBio...
Fuqua Professor David Ridley

Everything You Need to Know About FDA’s Priority Review Vouchers Worth $100’s of Millions.

Never Heard of These 'PRV's' but What a Potential Bonanza for the Recipients. They're transferable - as in they can be...